PEGFILGRASTIM for Soft tissue sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 19 adverse event reports in the FDA FAERS database where PEGFILGRASTIM was used for Soft tissue sarcoma.

Most Reported Side Effects for PEGFILGRASTIM

Side Effect	Reports	%	Deaths	Hosp.
Device adhesion issue	11,326	14.0%	9	12
Wrong technique in product usage process	10,217	12.6%	13	80
Unintentional medical device removal	8,882	11.0%	7	23
Device malfunction	6,818	8.4%	3	53
Device use error	6,001	7.4%	4	20
Device issue	5,071	6.3%	7	48
Accidental exposure to product	4,967	6.1%	1	13
Device occlusion	3,239	4.0%	3	13
Off label use	3,228	4.0%	140	299
Bone pain	2,266	2.8%	48	421
Febrile neutropenia	2,154	2.7%	237	1,203
Drug dose omission	2,089	2.6%	3	52
Drug dose omission by device	2,051	2.5%	3	26
Neutropenia	1,863	2.3%	163	659
Intercepted product preparation error	1,514	1.9%	1	1